Welcome to Cleveland Clinic Online Health Chats

Get answers to your health questions and concerns. It's easy to be part of our live chat events, led by Cleveland Clinic physicians and health professionals.

CANCELLED: Neurofibromatosis 2013: A Multisystem Disorder Requiring Multidisciplinary Care
Friday, May 10, 2013 - 2:30 PM (Eastern Time)

Sign up for this chat today.Register Now

Click Join Chat to join the chat in progress.You will be asked to login if you aren't already logged in.Join Chat

A. David Rothner, MD

  • Neurological Institute
  • Center for Pediatric Neurology
  • Cleveland Clinic

Neurofibromatoses are genetic disorders of the nervous system that affect the growth and development of nerve cell tissue. The disorders, known as neurofibromatosis type 1 (NF1) and neurofibromatosis type 2 (NF2), are currently treated through symptom control. During this free online chat, Dr. Rothner will answer your questions about the two types of disorders and their causes, symptoms, and treatment.

Neurofibromatosis is often inherited (passed on by family members through our genes), but 30% to 50% of people newly diagnosed with the disorder have no family history of the condition, which can arise spontaneously through a mutation (change) in the genes. Once this change has taken place, the mutant gene can be passed on to future generations. NF1 cannot be cured at this time, but symptoms can be followed and managed.

Click here to learn more about Neurobromatoses Type 1

Dr. A. David Rothner is Chairman Emeritus, Section of Child Neurology; Director, Pediatric/Adolescent Headache Program; and Director, Cleveland Clinic Center for Consumer Health Information.

Dr. Rothner received his medical degree from the University of Illinois College of Medicine. Following completion of an internship and junior residency in pediatrics at the Presbyterian-St. Luke’s Hospital in Chicago, he completed a senior residency in pediatrics at Columbia Presbyterian Medical Center’s Babies Hospital in New York City. Dr. Rothner continued his training at the Neurologic Institute of the Columbia Presbyterian Medical Center with a fellowship in pediatric neurology. He has been a member of the faculty of Pediatrics and Neurology in Cleveland Clinic since 1973.

Currently, Dr. Rothner is the Chairman Emeritus of the Section of Child Neurology at Cleveland Clinic. He serves as a Fellow of the American Academies of Pediatrics and Neurology, and has served on the advisory boards of the Epilepsy Foundation of America and the March of Dimes. Dr. Rothner directs the Pediatric/Adolescent Headache Program and directs the efforts of the Cleveland Clinic Center for Consumer Health Information in the Education Institute.

Dr. Rothner sits on the editorial boards of Pediatrics Today and Headache Quarterly. He has published over 250 original articles, book chapters, tapes, and reviews in the areas of epilepsy, headaches in children, and general pediatric neurology. He is the co-editor of the textbook, Headache in Children and Adolescents.

Cleveland Clinic Neurological Institute and Children’s Hospital Neurofibromatosis (NF) Clinic is a member of the Children’s Tumor Foundation’s NF Clinic Network (NFCN). Overseen by the Foundation’s Clinical Care Advisory Board and Medical Affairs Committee, the NFCN recognizes clinics that provide appropriate NF care through implementation of current consensus clinical care guidelines for NF. The Foundation promotes information sharing between those providing medical care to the NF population, and integrate NF clinical care and current NF research efforts. For more information on Cleveland Clinic’s Neurofibromatosis Clinic, please call 216.444.5559 or 800.223.2273, ext. 45559.

Be part of a free health talk about Neurofibromatosis 2013 at Cleveland Clinic. For more information, see Neurofibromatosis brochure .To attend, please call 216.444.3641 (locally) or 800.548.8502. Register online at www.clevelandclinic.org/healthtalks.

This Health Chat is currently open to allow you to submit questions. We will try to answer as many questions as possible during the chat. Please create an account to attend the chat and submit your questions.